Skip to main content
Erschienen in: Diabetology International 4/2012

01.12.2012 | Original article

Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan

verfasst von: Miho Takizawa, Naoko Iwasaki, Toshiyuki Yamamoto, Yasuko Uchigata, Yasuhiko Iwamoto

Erschienen in: Diabetology International | Ausgabe 4/2012

Einloggen, um Zugang zu erhalten

Abstract

Aims

Recent reports indicate that genomic rearrangements are novel causative mutations for maturity onset diabetes of the young (MODY). The aim of this study was to investigate genomic rearrangements in Japanese patients with MODY.

Methods

Subjects diagnosed with diabetes before the age of 30 years and clinically suspected of having MODY but without identified causative mutations were included in the study (n = 223). Multiplex ligation-dependent probe amplification (MLPA) assays were performed to detect genomic rearrangements in HNF4A, GCK, HNF1A, and HNF1B. Array comparative genomic hybridization (aCGH) was performed to confirm the presence and extent of complete gene deletion or duplications. To examine variation in exon copy number, a custom MODY-CGH microarray using the web-based Agilent eArray database was performed.

Results

Four subjects with a hemizygous deletion mutation at 17q12, including HNF1B and spanning 1.4 Mb, were identified. The clinical features of these patients corresponded to those of MODY5 patients. In addition, one case each with an exon copy number variation of GCK7 and HNF1B3 were identified by MLPA and confirmed by array CGH.

Conclusions

We identified four Japanese MODY cases with a genomic rearrangement in MODY5. Our data indicate that when diagnosing MODY5, the typical phenotype is more important than the family history because the cases detected occurred de novo. Moreover, we report the first Japanese cases with exonic copy number variation of the genes for MODY2 and 5.
Literatur
1.
Zurück zum Zitat Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med. 1974;43(170):339–57.PubMed Tattersall RB. Mild familial diabetes with dominant inheritance. Q J Med. 1974;43(170):339–57.PubMed
2.
Zurück zum Zitat Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity onset type of young people. Diabetes. 1975;24(1):44–53.PubMedCrossRef Tattersall RB, Fajans SS. A difference between the inheritance of classical juvenile-onset and maturity onset type of young people. Diabetes. 1975;24(1):44–53.PubMedCrossRef
3.
Zurück zum Zitat Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med. 1993;328(10):697–702.PubMedCrossRef Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt MA, Beckmann JS, Bell GI, Cohen D. Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med. 1993;328(10):697–702.PubMedCrossRef
4.
Zurück zum Zitat Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre JC, Froguel P, Bell GI. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996;384(6608):455–8.PubMedCrossRef Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM, Boriraj VV, Chen X, Cox NJ, Oda Y, Yano H, Le Beau MM, Yamada S, Nishigori H, Takeda J, Fajans SS, Hattersley AT, Iwasaki N, Hansen T, Pedersen O, Polonsky KS, Turner RC, Velho G, Chevre JC, Froguel P, Bell GI. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 1996;384(6608):455–8.PubMedCrossRef
5.
Zurück zum Zitat Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384–5.PubMedCrossRef Horikawa Y, Iwasaki N, Hara M, Furuta H, Hinokio Y, Cockburn BN, Lindner T, Yamagata K, Ogata M, Tomonaga O, Kuroki H, Kasahara T, Iwamoto Y, Bell GI. Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY. Nat Genet. 1997;17(4):384–5.PubMedCrossRef
6.
Zurück zum Zitat Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996;384(6608):458–60.PubMedCrossRef Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Signorini S, Stoffel M, Bell GI. Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1). Nature. 1996;384(6608):458–60.PubMedCrossRef
7.
Zurück zum Zitat Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 1997;17(2):138–9.PubMedCrossRef Stoffers DA, Ferrer J, Clarke WL, Habener JF. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet. 1997;17(2):138–9.PubMedCrossRef
8.
Zurück zum Zitat Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23(3):323–8.PubMedCrossRef Malecki MT, Jhala US, Antonellis A, Fields L, Doria A, Orban T, Saad M, Warram JH, Montminy M, Krolewski AS. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet. 1999;23(3):323–8.PubMedCrossRef
9.
Zurück zum Zitat Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes. 2001;50(Suppl 1):S94–100.PubMedCrossRef Frayling TM, Evans JC, Bulman MP, Pearson E, Allen L, Owen K, Bingham C, Hannemann M, Shepherd M, Ellard S, Hattersley AT. Beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors. Diabetes. 2001;50(Suppl 1):S94–100.PubMedCrossRef
10.
Zurück zum Zitat Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet. 1995;345(8950):648.PubMedCrossRef Ledermann HM. Is maturity onset diabetes at young age (MODY) more common in Europe than previously assumed? Lancet. 1995;345(8950):648.PubMedCrossRef
11.
Zurück zum Zitat Otani T, Yao K, Sato A, Iwasaki N, Higami Y, Kasahara T, Hirata Y. Inheritance of diabetes and clinical features in patients with non-insulin dependent diabetes (NIDDM) diagnosed before age of 25 years. J Jpn Diabetes Soc. 1987;30(8):739–46. Otani T, Yao K, Sato A, Iwasaki N, Higami Y, Kasahara T, Hirata Y. Inheritance of diabetes and clinical features in patients with non-insulin dependent diabetes (NIDDM) diagnosed before age of 25 years. J Jpn Diabetes Soc. 1987;30(8):739–46.
12.
Zurück zum Zitat Chèvre JC, Hani EH, Boutin P, Vaxillaire M, Blanché H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanné-Chantelot C, Velho G, Froguel P. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia. 1998;41(9):1017–23.PubMedCrossRef Chèvre JC, Hani EH, Boutin P, Vaxillaire M, Blanché H, Vionnet N, Pardini VC, Timsit J, Larger E, Charpentier G, Beckers D, Maes M, Bellanné-Chantelot C, Velho G, Froguel P. Mutation screening in 18 Caucasian families suggest the existence of other MODY genes. Diabetologia. 1998;41(9):1017–23.PubMedCrossRef
13.
Zurück zum Zitat Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34(3):207–16.PubMed Stride A, Hattersley AT. Different genes, different diabetes: lessons from maturity-onset diabetes of the young. Ann Med. 2002;34(3):207–16.PubMed
14.
Zurück zum Zitat Bellanné-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54(11):3126–32.PubMedCrossRef Bellanné-Chantelot C, Clauin S, Chauveau D, Collin P, Daumont M, Douillard C, Dubois-Laforgue D, Dusselier L, Gautier JF, Jadoul M, Laloi-Michelin M, Jacquesson L, Larger E, Louis J, Nicolino M, Subra JF, Wilhem JM, Young J, Velho G, Timsit J. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes. 2005;54(11):3126–32.PubMedCrossRef
15.
Zurück zum Zitat Ellard S, Thomas K, Edghill EL, Owens M, Ambye L, Cropper J, Little J, Strachan M, Stride A, Ersoy B, Eiberg H, Pedersen O, Shepherd MH, Hansen T, Harries LW, Hattersley AT. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia. 2007;50(11):2313–7.PubMedCrossRef Ellard S, Thomas K, Edghill EL, Owens M, Ambye L, Cropper J, Little J, Strachan M, Stride A, Ersoy B, Eiberg H, Pedersen O, Shepherd MH, Hansen T, Harries LW, Hattersley AT. Partial and whole gene deletion mutations of the GCK and HNF1A genes in maturity-onset diabetes of the young. Diabetologia. 2007;50(11):2313–7.PubMedCrossRef
16.
Zurück zum Zitat Carette C, Vaury C, Barthélémy A, Clauin S, Grünfeld JP, Timsit J, Bellanné-Chantelot C. Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J Clin Endocrinol Metab. 2007;92(7):2844–7.PubMedCrossRef Carette C, Vaury C, Barthélémy A, Clauin S, Grünfeld JP, Timsit J, Bellanné-Chantelot C. Exonic duplication of the hepatocyte nuclear factor-1beta gene (transcription factor 2, hepatic) as a cause of maturity onset diabetes of the young type 5. J Clin Endocrinol Metab. 2007;92(7):2844–7.PubMedCrossRef
17.
Zurück zum Zitat Aoki E, Takizawa M, Yanagisawa K, Harada M, Hanai K, Ishii A, Yago R, Iwasaki N, Iwamoto Y. A case of MODY5 associated with a complicated urinary tract infection. J Tokyo Women’s Med Univ. 2011;81:E247–52. Aoki E, Takizawa M, Yanagisawa K, Harada M, Hanai K, Ishii A, Yago R, Iwasaki N, Iwamoto Y. A case of MODY5 associated with a complicated urinary tract infection. J Tokyo Women’s Med Univ. 2011;81:E247–52.
18.
Zurück zum Zitat Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Müller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Grüters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab. 2009;94(7):2658–64.PubMedCrossRef Raile K, Klopocki E, Holder M, Wessel T, Galler A, Deiss D, Müller D, Riebel T, Horn D, Maringa M, Weber J, Ullmann R, Grüters A. Expanded clinical spectrum in hepatocyte nuclear factor 1b-maturity-onset diabetes of the young. J Clin Endocrinol Metab. 2009;94(7):2658–64.PubMedCrossRef
19.
Zurück zum Zitat Oram RA, Edghill EL, Blackman J, Taylor MJ, Kay T, Flanagan SE, Ismail-Pratt I, Creighton SM, Ellard S, Hattersley AT, Bingham C. Mutations in the hepatocyte nuclear factor-1beta (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol. 2010;203(4):364.e1–5.CrossRef Oram RA, Edghill EL, Blackman J, Taylor MJ, Kay T, Flanagan SE, Ismail-Pratt I, Creighton SM, Ellard S, Hattersley AT, Bingham C. Mutations in the hepatocyte nuclear factor-1beta (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol. 2010;203(4):364.e1–5.CrossRef
20.
Zurück zum Zitat Saillour Y, Cossée M, Leturcq F, Vasson A, Beugnet C, Poirier K, Commere V, Sublemontier S, Viel M, Letourneur F, Barbot JC, Deburgrave N, Chelly J, Bienvenu T. Detection of exonic copy-number changes using a highly efficient oligonucleotide-based comparative genomic hybridization-array method. Hum Mutat. 2008;29(9):1083–90.PubMedCrossRef Saillour Y, Cossée M, Leturcq F, Vasson A, Beugnet C, Poirier K, Commere V, Sublemontier S, Viel M, Letourneur F, Barbot JC, Deburgrave N, Chelly J, Bienvenu T. Detection of exonic copy-number changes using a highly efficient oligonucleotide-based comparative genomic hybridization-array method. Hum Mutat. 2008;29(9):1083–90.PubMedCrossRef
21.
Zurück zum Zitat Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, McMahon JM, Iona X, Carpintero RS, Elia M, Cilio MR, Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac O, Zara F, Berkovic SF, Guerrini R, Mulley JC. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia. 2009;50(7):1670–8.PubMedCrossRef Marini C, Scheffer IE, Nabbout R, Mei D, Cox K, Dibbens LM, McMahon JM, Iona X, Carpintero RS, Elia M, Cilio MR, Specchio N, Giordano L, Striano P, Gennaro E, Cross JH, Kivity S, Neufeld MY, Afawi Z, Andermann E, Keene D, Dulac O, Zara F, Berkovic SF, Guerrini R, Mulley JC. SCN1A duplications and deletions detected in Dravet syndrome: implications for molecular diagnosis. Epilepsia. 2009;50(7):1670–8.PubMedCrossRef
Metadaten
Titel
Whole gene deletion mutation of HNF1B and exonic aberration mutations of GCK and HNF1B in patients with MODY in Japan
verfasst von
Miho Takizawa
Naoko Iwasaki
Toshiyuki Yamamoto
Yasuko Uchigata
Yasuhiko Iwamoto
Publikationsdatum
01.12.2012
Verlag
Springer Japan
Erschienen in
Diabetology International / Ausgabe 4/2012
Print ISSN: 2190-1678
Elektronische ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-012-0084-9

Weitere Artikel der Ausgabe 4/2012

Diabetology International 4/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.